What is Ultragenyx Pharmaceutical's change in AR?

Ultragenyx Pharmaceutical (RARE) reported change in AR of -$19M in Q1 2026.

How has Ultragenyx Pharmaceutical's change in AR changed year-over-year?

Ultragenyx Pharmaceutical's change in AR decreased by 90.0% year-over-year, from -$10M to -$19M.

What is the long-term trend for Ultragenyx Pharmaceutical's change in AR?

Over 2 years (2021 to 2025), Ultragenyx Pharmaceutical's change in AR has grown at a 132.1% compound annual growth rate (CAGR), from $5.76M to $31M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Ultragenyx Pharmaceutical RARE Change in AR

Change in AR at other companies

AmgenAMGN

-$413M-132%

Arrowhead ResearchARWR

$212.05M+8,382%

CRISPR TherapeuticsCRSP

$0+100%

ModernaMRNA

-$114M+59.3%

BridgeBio PharmaBBIO

$65.78M-40.5%

Catalyst PharmaceuticalCPRX

$4.36M-24.7%

Other financials

Income statement

See full

Revenue$136.0M-2.2%

Operating income-$169.0M-18.2%

Net income-$185.0M-22.5%

EPS (diluted)-$1.84-17.2%

Balance sheet

See full

Cash & equivalents$175.0M+37.8%

Total debt$36.0M-10.8%

Total equity-$236.0M-264%

Total assets$1.3B-1.2%

Cash flow

See full

Operating cash flow-$197.0M-18.7%

CapEx$1.0M0.0%

Free cash flow-$198.0M-18.6%

Valuation

See full

Market cap$2.83B-39.4%

P/S4.2×-3.7×

Profitability

See full

Gross margin97.2%—

Operating margin-83.8%-3.0pp

Net margin-90.9%-2.1pp

FCF margin-75.1%+10.7pp

Returns & leverage

See full

Return on equity-325.6%+36.9pp

Debt / equity3.7×—

Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's change in AR?: Ultragenyx Pharmaceutical (RARE) reported change in AR of -$19M in Q1 2026.
How has Ultragenyx Pharmaceutical's change in AR changed year-over-year?: Ultragenyx Pharmaceutical's change in AR decreased by 90.0% year-over-year, from -$10M to -$19M.
What is the long-term trend for Ultragenyx Pharmaceutical's change in AR?: Over 2 years (2021 to 2025), Ultragenyx Pharmaceutical's change in AR has grown at a 132.1% compound annual growth rate (CAGR), from $5.76M to $31M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.